OptimizeRx (OPRX) Receivables - Net (2010 - 2026)

OptimizeRx has disclosed Receivables - Net across 17 years of filings, most recently posting $24.8 million for Q2 2026.

• In Q2 2026, Receivables - Net fell 26.01% year-over-year to $24.8 million; the TTM figure through Jun 2026 stood at $24.8 million (down 26.01% YoY), while the FY2025 annual figure was $37.8 million, down 1.2% from the prior year.
• Receivables - Net came in at $24.8 million for Q2 2026 at OptimizeRx, down from $32.0 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $38.2 million in Q4 2024 to a low of $17.8 million in Q3 2022.
• Average Receivables - Net over 5 years is $26.8 million, with a median of $25.6 million recorded in 2024.
• Year-over-year, Receivables - Net soared 63.77% in 2024 and dropped 26.01% in 2026.
• Over 5 years, Receivables - Net stood at $22.2 million in 2022, then soared by 63.63% to $36.3 million in 2023, then climbed by 5.4% to $38.2 million in 2024, then slipped by 1.2% to $37.8 million in 2025, then slumped by 34.32% to $24.8 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $24.8 million in Q2 2026, $32.0 million in Q1 2026, and $37.8 million in Q4 2025.